Surgery Partners (SGRY) Long-Term Investments (2014 - 2026)

Surgery Partners has disclosed Long-Term Investments across 13 years of filings, most recently posting $225.4 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $225.4 million, up 3.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $225.4 million (up 3.11% YoY), and the FY2025 annual result was $234.0 million, up 8.64% from the prior year.
• Long-Term Investments came in at $225.4 million for Q1 2026 at Surgery Partners, down from $234.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $234.0 million in Q4 2025 to a low of $94.5 million in Q1 2022.
• The 5-year median for Long-Term Investments is $196.3 million (2023), against an average of $198.3 million.
• Across the five-year window, Long-Term Investments jumped 114.54% in 2022 and slipped 3.26% in 2023, its largest moves.
• Surgery Partners' Long-Term Investments stood at $190.3 million in 2022, then fell by 3.26% to $184.1 million in 2023, then grew by 17.0% to $215.4 million in 2024, then increased by 8.64% to $234.0 million in 2025, then fell by 3.68% to $225.4 million in 2026.
• The last three Long-Term Investments figures came in at $225.4 million (Q1 2026), $234.0 million (Q4 2025), and $229.4 million (Q3 2025), per Business Quant data.